10-49474074-A-T
Variant summary
Our verdict is Pathogenic. The variant received 22 ACMG points: 22P and 0B. PS1_Very_StrongPM2PP3_StrongPP5_Very_Strong
The NM_000124.4(ERCC6):c.2551T>A(p.Trp851Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar.
Frequency
Consequence
NM_000124.4 missense
Scores
Clinical Significance
Conservation
Publications
- Cockayne spectrum with or without cerebrooculofacioskeletal syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Cockayne syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Orphanet, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- UV-sensitive syndrome 1Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- COFS syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- UV-sensitive syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- premature ovarian failure 11Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 22 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ERCC6 | ENST00000355832.10 | c.2551T>A | p.Trp851Arg | missense_variant | Exon 13 of 21 | 1 | NM_000124.4 | ENSP00000348089.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cockayne syndrome type 2 Pathogenic:3
- -
- -
The study of the W851R mutation in the ERCC6 gene is central to understanding the complex pathophysiological processes associated with Cockayne Syndrome (CS). While this variant has been noted in earlier research, its specific impact on the structural integrity of the ERCC6 protein and subsequent changes in its ATPase activity have not been thoroughly examined until now. Our research represents the initial effort to fully analyze the severe consequences of this missense mutation, which appears deceptively benign. Previous studies (Mallery 1998, Laugel 2010, Batenburg 2015) have highlighted the profound negative effects of the W851R mutation on ERCC6 functionality. It has been demonstrated that this mutation results in an ERCC6 protein that lacks DNA-dependent ATPase activity, leading to a disruption in chromatin remodeling and hindering essential repair processes. These findings align with our molecular dynamic simulations, which indicate compromised ATPase and DNA binding functions of the protein. -
Cerebrooculofacioskeletal syndrome 1;C0242379:Lung cancer;C0265201:DE SANCTIS-CACCHIONE SYNDROME;C0751038:Cockayne syndrome type 2;C3151063:Age related macular degeneration 5;C3551173:UV-sensitive syndrome 1;C4310783:Premature ovarian failure 11 Pathogenic:1
- -
not provided Pathogenic:1
ClinVar contains an entry for this variant (Variation ID: 522698). This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 851 of the ERCC6 protein (p.Trp851Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Cockayne syndrome (PMID: 9443879, 29572252, 32557569). This variant is also known as T2630A. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ERCC6 protein function. Experimental studies have shown that this missense change affects ERCC6 function (PMID: 9443879). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at